BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 34862288)

  • 1. Liothyronine for hypothyroidism: a candidate for disinvestment or in need of further research? A value of information analysis.
    Hughes DA; Skiadas K; Fitzsimmons D; Anderson P; Heald A
    BMJ Open; 2021 Dec; 11(12):e051702. PubMed ID: 34862288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined levothyroxine plus liothyronine compared with levothyroxine alone in primary hypothyroidism: a randomized controlled trial.
    Clyde PW; Harari AE; Getka EJ; Shakir KM
    JAMA; 2003 Dec; 290(22):2952-8. PubMed ID: 14665656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual function and depressive symptoms in young men with hypothyroidism receiving levothyroxine/liothyronine combination therapy.
    Krysiak R; Marek B; Okopień B
    Endokrynol Pol; 2018; 69(1):16-22. PubMed ID: 29319127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. REVIEW: Treatment of hypothyroidism with combinations of levothyroxine plus liothyronine.
    Escobar-Morreale HF; Botella-Carretero JI; Escobar del Rey F; Morreale de Escobar G
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4946-54. PubMed ID: 15928247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liothyronine (LT3) prescribing in England: Are cost constraints inhibiting guideline implementation?
    Ah H; Ld P; Pn T; Depesina D; Chaudhury N; Oe O; M S; Cm D
    Clin Endocrinol (Oxf); 2024 Jul; 101(1):62-68. PubMed ID: 38752469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hypothyroidism with levothyroxine or a combination of levothyroxine plus L-triiodothyronine.
    Escobar-Morreale HF; Botella-Carretero JI; Morreale de Escobar G
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):57-75. PubMed ID: 25617173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does combination T4 and T3 therapy make sense?
    McDermott MT
    Endocr Pract; 2012; 18(5):750-7. PubMed ID: 22548953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of liothyronine (T3) in hypothyroidism: Joint British Thyroid Association/Society for endocrinology consensus statement.
    Ahluwalia R; Baldeweg SE; Boelaert K; Chatterjee K; Dayan C; Okosieme O; Priestley J; Taylor P; Vaidya B; Zammitt N; Pearce SH
    Clin Endocrinol (Oxf); 2023 Aug; 99(2):206-216. PubMed ID: 37272400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone.
    Escobar-Morreale HF; Botella-Carretero JI; Gómez-Bueno M; Galán JM; Barrios V; Sancho J
    Ann Intern Med; 2005 Mar; 142(6):412-24. PubMed ID: 15767619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual function and depressive symptoms in young women with hypothyroidism receiving levothyroxine/liothyronine combination therapy: a pilot study.
    Krysiak R; Szkróbka W; Okopień B
    Curr Med Res Opin; 2018 Sep; 34(9):1579-1586. PubMed ID: 29508635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in costs and prescribing for liothyronine and levothyroxine in England and wales 2011-2020.
    Stedman M; Taylor P; Premawardhana L; Okosieme O; Dayan C; Heald AH
    Clin Endocrinol (Oxf); 2021 Jun; 94(6):980-989. PubMed ID: 33411974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of liothyronine therapy in hypothyroidism: a randomized, double-blind, crossover trial of liothyronine versus levothyroxine.
    Celi FS; Zemskova M; Linderman JD; Smith S; Drinkard B; Sachdev V; Skarulis MC; Kozlosky M; Csako G; Costello R; Pucino F
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3466-74. PubMed ID: 21865366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of Patients Symptomatically Unresponsive to Levothyroxine: Natural Desiccated Thyroid Extract or the Combination of Levothyroxine and Liothyronine? A Research Priority.
    Heald A; Livingston M; Hughes D
    Exp Clin Endocrinol Diabetes; 2020 Sep; 128(9):596-598. PubMed ID: 31820425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of combined levothyroxine and liothyronine as compared with levothyroxine monotherapy in primary hypothyroidism: a randomized controlled trial.
    Valizadeh M; Seyyed-Majidi MR; Hajibeigloo H; Momtazi S; Musavinasab N; Hayatbakhsh MR
    Endocr Res; 2009; 34(3):80-9. PubMed ID: 19701833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Key data from the 2022 European Thyroid Association congress: Treatment of primary hypothyroidism: Levothyroxine alone or a combination of levothyroxine and liothyronine?
    Caron P
    Ann Endocrinol (Paris); 2023 Dec; 84(6):751-753. PubMed ID: 37285954
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document.
    Jonklaas J; Bianco AC; Cappola AR; Celi FS; Fliers E; Heuer H; McAninch EA; Moeller LC; Nygaard B; Sawka AM; Watt T; Dayan CM
    Thyroid; 2021 Feb; 31(2):156-182. PubMed ID: 33276704
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism.
    Jonklaas J
    Endocrinol Metab Clin North Am; 2022 Jun; 51(2):243-263. PubMed ID: 35662440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Daily Administration of Short-Acting Liothyronine Is Associated with Significant Triiodothyronine Excursions and Fails to Alter Thyroid-Responsive Parameters.
    Jonklaas J; Burman KD
    Thyroid; 2016 Jun; 26(6):770-8. PubMed ID: 27030088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substitution of liothyronine at a 1:5 ratio for a portion of levothyroxine: effect on fatigue, symptoms of depression, and working memory versus treatment with levothyroxine alone.
    Rodriguez T; Lavis VR; Meininger JC; Kapadia AS; Stafford LF
    Endocr Pract; 2005; 11(4):223-33. PubMed ID: 16006298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination Therapy for Hypothyroidism: Rationale, Therapeutic Goals, and Design.
    Madan R; Celi FS
    Front Endocrinol (Lausanne); 2020; 11():371. PubMed ID: 32733377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.